Lung Diseases, Interstitial: all 656 studies

Page 4 of 7. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• The Natural History of Small Airways Physiology in Diseased and Healthy StatesCompletedNCT00677560Results posted
• Rituximab in Rheumatoid Arthritis Lung DiseaseCompletedNCT00578565Phase 3Results posted
• Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant TacrolimusCompletedNCT00504348Phase 2/3Results posted
• Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone ConsultationCompletedNCT00129701Not applicableResults posted
• Validation of AI-Based Detection of Idiopathic Pulmonary Fibrosis in Serial Chest Radiographs: A Retrospective Longitudinal StudyCompletedNCT07712952
• The Effects of Whole-Body Vibration Training on Clinical and Functional Outcomes in Individuals Diagnosed With Interstitial Lung DiseaseCompletedNCT07709260Not applicable
• Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest RadiographyCompletedNCT07686562
• Nasal High-flow Oxygen Therapy During Rehabilitive Exercise Training in ILDCompletedNCT07679854Not applicable
• Hereditary Influences on Pulmonary Fibrosis TrajectoriesActive, not recruitingNCT07580053
• Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases.Active, not recruitingNCT07577115
• Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 TrialActive, not recruitingNCT07486206Not applicable
• Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With IloprostCompletedNCT07478094
• Diagnostic Yield and Safety of Lung Biopsy Techniques in Interstitial Lung DiseasesCompletedNCT07432503Not applicable
• Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary FibrosisActive, not recruitingNCT07396467
• Corticosteroid Therapy in Pulmonary Sequelae of Covid-19CompletedNCT07380152Phase 1
• Acute Hemodynamic Responses to Blood Flow Restriction Aerobic Exercise in Interstitial Lung DiseaseActive, not recruitingNCT07315425Not applicable
• Generative AI Impact on Rheumatoid Arthritis Complications DiagnosisCompletedNCT07301892
• Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the LungActive, not recruitingNCT07202260
• Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)SuspendedNCT07181382Phase 3
• Prognostic Score Comparison in IPF and HPCompletedNCT07169253
• BAL Contribution to Lung Cryo-TBB in ILDCompletedNCT07130110Not applicable
• Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung DiseaseCompletedNCT07129707Not applicable
• Validity and Reliability of the 6-Minute Pegboard and Ring Test in Interstitial Lung DiseaseActive, not recruitingNCT07122141
• A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung FibrosisActive, not recruitingNCT07080125
• Impact of Lung Boost Device on Ventilatory Functions and Fatigue in Patients With Interstitial Lung DiseasesCompletedNCT06991153Not applicable
• Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary PneumoniaCompletedNCT06924749Phase 2
• Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Active, not recruitingNCT06843239Phase 2
• Lung Cancer Screening CT for FirefightersWithdrawnNCT06836414Not applicable
• A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic DiseasesActive, not recruitingNCT06806592Phase 3
• Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMFCompletedNCT06758947Phase 3
• Confocal Laser Endomicroscopy Guided Cryobiopsy in the Diagnosis of Interstitial Lung DiseaseCompletedNCT06741826Not applicable
• Interstitial Lung Disease Exacerbations StudyActive, not recruitingNCT06685874
• Phase 2 Study of Rapcabtagene Autoleucel in MyositisActive, not recruitingNCT06665256Phase 2
• Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPDActive, not recruitingNCT06636487Not applicable
• A Study of Mosliciguat in PH-ILDActive, not recruitingNCT06635850Phase 2
• Digital Modeling of Thoracic CT and Pulmonary FibrosisActive, not recruitingNCT06618924
• Evaluation of the Effectiveness, Safety, and Cost of a Smart Home-based Hospital System for Patients With Interstitial Lung Disease: Prospective Multicenter Randomized Controlled TrialActive, not recruitingNCT06601790Not applicable
• Interstitial Lung Disease is a Risk Factor for Cardiovascular DiseaseCompletedNCT06539962
• Role of Lung Ultrasound in Screening for Interstitial Lung Disease in Patients With Rheumatoid ArthritisCompletedNCT06531785
• Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory DiseasesCompletedNCT06447831
• Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung DiseasesCompletedNCT06385301Not applicable
• Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19CompletedNCT06383819Phase 3
• A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisActive, not recruitingNCT06329401Phase 2
• Value of Chest Ultrasonography in ILD ScreeningCompletedNCT06260930
• Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILDTerminatedNCT06192004
• Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?CompletedNCT06174207Not applicable
• Risk Factors and Prognostic Parameters of Interstitial Lung Disease in ChildrenStatus unknownNCT06125288
• A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisActive, not recruitingNCT06025578Phase 3
• Specialist Dietetic Intervention in Malnourished Patients with Fibrotic ILD: a Randomised Controlled Pilot TrialCompletedNCT06016959Not applicable
• The Study of Sleep Disordered Breathing in Patients With Interstitial Lung DiseasesCompletedNCT06012526
• Interstitial Lung Disease AssociatedCompletedNCT06007040
• Effects of Respiratory Muscle Functions on Interstitial Lung Disease: Sleep Quality, Dyspnea, and FatigueCompletedNCT05993520
• Rituxmab Versus IL-6 in Treating ILDCompletedNCT05963048Phase 2/3
• Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Active, not recruitingNCT05925803Phase 3
• Effects of Upper Extremity Aerobic Exercise Training in Patients With Interstitial Lung DiseaseCompletedNCT05916404Not applicable
• Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney DiseaseCompletedNCT05914909Phase 1
• Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy AdultsCompletedNCT05894148Phase 1
• Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILDActive, not recruitingNCT05867914Not applicable
• Muscles Oxygenation During Exercise in Fibrosing Interstitial Lung DiseasesCompletedNCT05855447
• Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk FactorsCompletedNCT05855109
• Anlotinib Capsules in the Treatment for IPF/PF-ILDsActive, not recruitingNCT05828953Phase 2
• Integrating ePReBMs From Phoenix in Respiratory DiseasesTerminatedNCT05827302Not applicable
• Effect of Pulmonary Telerehabilitation and Telemonitoring for Patients With Chronic Respiratory DiseasesCompletedNCT05824910Not applicable
• A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-upCompletedNCT05810493
• An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical DoctorsCompletedNCT05784207
• Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionCompletedNCT05776225
• Novel Markers of Disease Progression in Interstitial Lung DiseaseStatus unknownNCT05760508
• NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung DiseasesCompletedNCT05722340Not applicable
• Assessment of Neuropsychiatric Function in Patients With Interstitial Lung DiseaseCompletedNCT05719233
• Hiatal Hernia and Pulmonary InvolvementCompletedNCT05716022
• Opportunistic Screening for Osteoporotic Vertebral Fractures in Patients With Diffuse Interstitial Lung DiseaseCompletedNCT05714787
• ILD: Health Outcomes in Remote Digital Monitoring Versus Usual CareActive, not recruitingNCT05662124Not applicable
• An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)CompletedNCT05649722Phase 2/3
• Correlation Between PaO2/FiO2 and Lung Ultrasound Score in the Intensive Care UnitCompletedNCT05631756Not applicable
• May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?Status unknownNCT05631132Not applicable
• Remote Assessment of Lung Disease and Impact on Physical and Mental HealthStatus unknownNCT05630599
• An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity PneumonitisActive, not recruitingNCT05626387Phase 4
• A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)No longer availableNCT05624281
• Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) PatientsTerminatedNCT05503030
• A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung DiseaseCompletedNCT05492994Not applicable
• Monitoring and Evaluation Study of Project ECHO for ILDStatus unknownNCT05455437
• Patient-Reported Outcome Study of Project ECHO for ILDStatus unknownNCT05450276
• Pulmonary Care and Research Collaborative Patient RegistryStatus unknownNCT05445817
• Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisCompletedNCT05415137Phase 3
• Using Thoracic Ultrasound to Detect Interstitial Lung Disease in Patients With Rheumatoid ArthritisCompletedNCT05396469
• Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive DermatomyositisStatus unknownNCT05375435Phase 4
• Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung DiseasesStatus unknownNCT05372926Not applicable
• FAPI PET for Lung FibrosisActive, not recruitingNCT05365802Early Phase 1
• Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung DiseaseTerminatedNCT05335278Not applicable
• Integration of Cryobiopsies for ILD Diagnoses- Experience Based on 250 Biopsy Procedures.CompletedNCT05311345
• Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)Active, not recruitingNCT05270668Phase 2
• Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise ToleranceTerminatedNCT05267418Not applicable
• Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.Status unknownNCT05246293Phase 2
• Effects of Exercise Training on Respiratory Performance in Patients With Fibrosing Interstitial Lung DiseasesCompletedNCT05227443Not applicable
• The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic DiseasesStatus unknownNCT05181397Phase 2
• Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung DiseaseWithdrawnNCT05177471
• A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung DiseaseCompletedNCT05176951Phase 2
• Telerehabilitation in Patients With Fibrosing Interstitial Lung DiseasesCompletedNCT05166057Not applicable
• INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world EvaluationCompletedNCT05151640
• The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial IntelligenceCompletedNCT05146934

← Lung Diseases, Interstitial overview